Abstract：Objective: To analyze the expression of β-catenin and ILK in gallbladder carcinoma and its correlation with clinicopathologic parameters. Methods: 75 cases of cholecystitis associated with cholecystitis from April 2013 to May 2016 were selected. According to the results of pathological examination, 47 cases were gallbladder carcinoma, 13 cases were cystic polyps, and 15 cases were chronic cholecystitis. The expression levels of β-catenin and ILK were measured. Results: The expression of ILK, β -catenin in gallbladder carcinoma was significantly higher than that in cystic polyps and chronic cholecystitis (P<0.05). The positive rates of ILK and β-catenin in patients with tumor diameter ≥ 2cm were higher than those in patients with tumor diameter < 2cm, and the difference of positive rate of β -catenin was statistically significant (P<0.05). The positive rates of ILK and β -catenin in patients with different pathological differentiation degrees were significantly different. The positive rates of ILK and β -catenin from high to low were high differentiation, middle differentiation and low differentiation. The positive rate of ILK and β -catenin in serous infiltration patients was higher than that in non-serous infiltration patients (P<0.05). The positive rate of ILK and β -catenin in patients with lymph node metastasis was significantly higher than that in patients without lymph node metastasis (P<0.05). There was a significant positive correlation between the positive rate of LLK and β -catenin in gallbladder carcinoma (P<0.05). Conclusion: The positive rates of β -catenin and ILK in gallbladder carcinoma tissues are significantly increased, and the increased expression level of β -catenin and ILK may indicate the increase of invasion and lymph node metastasis risk, and the expression of β -catenin and ILK is positively correlated with the expression of β -catenin in gallbladder carcinoma.
徐丹,许海周. 胆囊癌组织中β-catenin和ILK的表达及其与临床病理参数的相关性研究[J]. 河北医学, 2018, 24(11): 1790-1793.
XU Dan, et al. Expression of β-catenin and ILK in Gallbladder Carcinoma and the Correlation with Clinicopathological Parameters. HeBei Med, 2018, 24(11): 1790-1793.
[1] 毛拉艾沙·买买提,依马木买买提江·阿不拉,薛峰.胆囊癌的外科疗效及预后影响因素分析[J].中国普通外科杂志,2012,21(09):1166~1169. [2] 邹声泉.胆囊癌发生发展机制的研究现状[J].中国实用外科杂志,2011,31(03):192~194. [3] Moon W, Park H, Lee H, et al.Co-expression of Cox-2, C-Met and beta-catenin in cells forming invasive front of gallbladder cancer[J]. Cancer Res, 2005,37:171~176. [4] 包人月,严小军,刘建新.Tankyrases的抑制作用于经典Wnt途径:治疗癌症的新靶点[J].中国细胞生物学学报,2012,34(11):1134~1140. [5] 李胜水,张凤梅,李秀清,等.ILK和E-Cad蛋白表达与食管鳞癌浸润转移的关系[J].现代肿瘤医学,2015,(6):808~811. [6] 白东.EMT相关标记分子和ILK在结直肠癌组织中的表达相关性及其与患者癌细胞侵袭转移CT征象的关系[J].中国医疗器械信息,2018,(4):11~12,77. [7] 李双标,李胜水,许华,等.整合素连接激酶(ILK)在早期肝病、肝硬化及肝细胞癌组织中表达及临床意义[J].首都医药,2013,(24):36~37. [8] 殷雷,邱法波,吴昌亮,等.中国近30年胆囊腺肌增生症流行病学特征及诊治经验[J].中国现代医学杂志,2012,22(18):66~70. [9] 裴广均,陈莉莉,刘玉琴,等.兰州市2005-2008年胆囊癌发病及流行趋势分析[J].中华肿瘤防治杂志,2015,22(21):1654~1657. [10] 张超,陈璐,余日胜.胆囊腺瘤及其局部癌变的MRI诊断[J].临床放射学杂志,2016,35(01):85~88. [11] 张潇月,唐少珊.超声造影鉴别诊断胆囊良恶性病变Meta分析[J].中国医学影像技术,2015,31(09):1340~1343. [12] Mislav Raki,Leonardo Patrlj,Mario Kopljar,Robert Kliek,等.胆囊癌的临床诊疗现状与挑战[J].中国普通外科杂志,2016,25(02):157~161. [13] Rai R, Tewari M, Kumar M, Singh AK, Shukla HS.p53: its alteration and gallbladder cancer[J].Eur Cancer Prev 2011,20(2):77~85. [14] 李华,周德俊.Wnt2/β-catenin信号通路及其在肿瘤中的作用[J].广东医学,2015,36(02):320~323.
2018, Vol. 24 
冀公网安备13080202000677号